CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients

Cancer Immunology, Immunotherapy

Volumn 62, Issue 1, 2013, Pages 113-124

  Borge, Mercedes ^a,d   Nannini, Paula Romina ^a,d   Morande, Pablo Elías ^a,d   Jancic, Carolina ^a,d   Bistmans, Alicia ^b   Bezares, Raimundo Fernando ^c   Giordano, Mirta ^a,d   Gamberale, Romina ^a,d  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^b HOSPITAL RAMOS MEJÍA   (Argentina)

^c HOSPITAL DURAND   (Argentina)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Chronic lymphocytic leukemia; CXCL12; Nurse like cells; T cell activation

Indexed keywords

CD3 ANTIGEN; CD40 LIGAND; CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY CD3; PROTEIN KINASE ZAP 70; STROMAL CELL DERIVED FACTOR 1;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STROMA CELL; T LYMPHOCYTE ACTIVATION; TUMOR MICROENVIRONMENT; UPREGULATION;

ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SEPARATION; CHEMOKINE CXCL12; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE ACTIVATION; MICROSCOPY, CONFOCAL;

EID: 84872497343     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1320-7     Document Type: Article

References (43)

1. Rosati S, Kluin PM (2005) Chronic lymphocytic leukaemia: a review of the immuno-architecture. Curr Top Microbiol Immunol 294:91-107
2. Soma LA, Craig FE, Swerdlow SH (2006) The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol 37(2):152-159
3. Ghia P, Circosta P, Scielzo C, Vallario A, Camporeale A, Granziero L, Caligaris-Cappio F (2005) Differential effects on CLL cell survival exerted by different microenvironmental elements. Curr Top Microbiol Immunol 294:135-145
4. Caligaris-Cappio F (2003) Role of the microenvironment in chronic lymphocytic leukaemia. Br J Haematol 123(3):380-388
5. Shanafelt T, Kay N (2006) T-cell abnormalities in patients with chronic lymphocytic leukemia. Leuk Lymphoma 47(7):1197-1198
6. Scrivener S, Goddard RV, Kaminski ER, Prentice AG (2003) Abnormal T-cell function in B-cell chronic lymphocytic leukaemia. Leuk Lymphoma 44(3):383-389
7. Ravandi F, O'Brien S (2006) Immune defects in patients with chronic lymphocytic leukemia. Cancer Immunol Immunother 55(2):197-209
8. Gorgun G, Holderried TA, Zahrieh D, Neuberg D, Gribben JG (2005) Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. J Clin Invest 115(7):1797-1805
9. Fluckiger AC, Rossi JF, Bussel A, Bryon P, Banchereau J, Defrance T (1992) Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 80(12):3173-3181
10. Buske C, Gogowski G, Schreiber K, Rave-Frank M, Hiddemann W, Wormann B (1997) Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand. Exp Hematol 25(4):329-337
11. Bagnara D, Kaufman MS, Calissano C, Marsilio S, Patten PE, Simone R, Chum P, Yan XJ, Allen SL, Kolitz JE, Baskar S, Rader C, Mellstedt H, Rabbani H, Lee A, Gregersen PK, Rai KR, Chiorazzi N (2011) A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Blood 117(20):5463-5472
12. Nishio M, Endo T, Tsukada N, Ohata J, Kitada S, Reed JC, Zvaifler NJ, Kipps TJ (2005) Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 106(3):1012-1020
13. Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell'Aquila M, Kipps TJ (2000) Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 96(8):2655-2663
14. Caligaris-Cappio F, Ghia P (2008) Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease? J Clin Oncol 26(27):4497-4503
15. Burkle A, Niedermeier M, Schmitt-Graff A, Wierda WG, Keating MJ, Burger JA (2007) Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood 110(9):3316-3325
16. Burger JA, Kipps TJ (2006) CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107(5):1761-1767
17. Tsukada N, Burger JA, Zvaifler NJ, Kipps TJ (2002) Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukemia. Blood 99(3):1030-1037
18. O'Hayre M, Salanga CL, Kipps TJ, Messmer D, Dorrestein PC, Handel TM (2010) Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis. PLoS One 5(7):e11716
19. Borge M, Nannini PR, Galletti JG, Morande PE, Avalos JS, Bezares RF, Giordano M, Gamberale R (2010) CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia. Haematologica 95(5):768-775
20. Nanki T, Lipsky PE (2000) Cutting edge: stromal cell-derived factor-1 is a costimulator for CD4+ T cell activation. J Immunol 164(10):5010-5014
21. Gamberale R, Fernandez-Calotti P, Sanjurjo J, Arrossagaray G, Avalos JS, Geffner J, Giordano M (2005) Signaling capacity of FcgammaRII isoforms in B-CLL cells. Leuk Res 29(11):1277-1284
22. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marce S, Lopez-Guillermo A, Campo E, Montserrat E (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 348(18):1764-1775
23. Chattopadhyay PK, Yu J, Roederer M (2006) Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression. Nat Protoc 1(1):1-6
24. Crawford MP, Yan SX, Ortega SB, Mehta RS, Hewitt RE, Price DA, Stastny P, Douek DC, Koup RA, Racke MK, Karandikar NJ (2004) High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103(11):4222-4231
25. Galletti J, Canones C, Morande P, Borge M, Oppezzo P, Geffner J, Bezares R, Gamberale R, Giordano M (2008) Chronic lymphocytic leukemia cells bind and present the erythrocyte protein band 3: possible role as initiators of autoimmune hemolytic anemia. J Immunol 181(5):3674-3683
26. D'Arena G, Tarnani M, Rumi C, Vaisitti T, Aydin S, De Filippi R, Perrone F, Pinto A, Chiusolo P, Deaglio S, Malavasi F, Laurenti L (2007) Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia. Am J Hematol 82(9):787-791
27. Del Giudice I, Morilla A, Osuji N, Matutes E, Morilla R, Burford A, Maravelaki S, Owusu-Ankomah K, Swansbury J, A'Hern R, Brito-Babapulle V, Catovsky D (2005) Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia. Cancer 104(10):2124-2132
28. Schroers R, Griesinger F, Trumper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Duhrsen U, Durig J (2005) Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 19(5):750-758
29. Hus I, Podhorecka M, Bojarska-Junak A, Rolinski J, Schmitt M, Sieklucka M, Wasik-Szczepanek E, Dmoszynska A (2006) The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia. Ann Oncol 17(4):683-690
30. Dighiero G, Binet JL (2000) When and how to treat chronic lymphocytic leukemia. N Engl J Med 343(24):1799-1801
31. Tangye SG, Weston KM, Raison RL (1997) Cytokines and cross-linking of sIgM augment PMA-induced activation of human leukaemic CD5+ B cells. Immunol Cell Biol 75(6):561-567
32. Buschle M, Campana D, Carding SR, Richard C, Hoffbrand AV, Brenner MK (1993) Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med 177(1):213-218
33. Gamberale R, Geffner JR, Giordano M (2002) Immune complexes and apoptosis in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 43(2):251-255
34. Ghia P, Strola G, Granziero L, Geuna M, Guida G, Sallusto F, Ruffing N, Montagna L, Piccoli P, Chilosi M, Caligaris-Cappio F (2002) Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22. Eur J Immunol 32(5):1403-1413
35. Patten PE, Buggins AG, Richards J, Wotherspoon A, Salisbury J, Mufti GJ, Hamblin TJ, Devereux S (2008) CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood 111(10):5173-5181
36. Murdoch C (2000) CXCR4: chemokine receptor extraordinaire. Immunol Rev 177:175-184
37. Molon B, Gri G, Bettella M, Gomez-Mouton C, Lanzavecchia A, Martinez AC, Manes S, Viola A (2005) T cell costimulation by chemokine receptors. Nat Immunol 6(5):465-471
38. Suzuki Y, Rahman M, Mitsuya H (2001) Diverse transcriptional response of CD4(+) T cells to stromal cell-derived factor (SDF)-1: cell survival promotion and priming effects of SDF-1 on CD4(+) T cells. J Immunol 167(6):3064-3073
39. Kumar A, Humphreys TD, Kremer KN, Bramati PS, Bradfield L, Edgar CE, Hedin KE (2006) CXCR4 physically associates with the T cell receptor to signal in T cells. Immunity 25(2):213-224
40. Amara A, Lorthioir O, Valenzuela A, Magerus A, Thelen M, Montes M, Virelizier JL, Delepierre M, Baleux F, Lortat-Jacob H, Arenzana-Seisdedos F (1999) Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J Biol Chem 274(34):23916-23925
41. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F (2005) The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280(42):35760-35766
42. Granziero L, Ghia P, Circosta P, Gottardi D, Strola G, Geuna M, Montagna L, Piccoli P, Chilosi M, Caligaris-Cappio F (2001) Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood 97(9):2777-2783
43. Gamberale R, Geffner J, Arrosagaray G, Scolnik M, Salamone G, Trevani A, Vermeulen M, Giordano M (2001) Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis. Leukemia 15(12):1860-1867